Finance

Lists
Why is 4AB up ३.२९%?
Dive Deeper
4AB:ETR
AbbVie Common Stock
€ २४४.६०
+३.२९%
(+७.८०) 1D
अक्टोबर ७, १७:३५:४१ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4AB...
Open
€ २३८.२०
High
€ २४४.६०
Low
€ २३८.००
Mkt. cap
४.८० खरब
Avg. vol.
६७२.००
Volume
३५२.००
52-wk high
€ २४४.६०
52-wk low
€ १६२.८५
No. of employees
५७ हजार
Open
€ २३८.२०
High
€ २४४.६०
Low
€ २३८.००
Mkt. cap
४.८० खरब
Avg. vol.
६७२.००
Volume
३५२.००
52-wk high
€ २४४.६०
52-wk low
€ १६२.८५
No. of employees
५७ हजार
News stories
From web sources and news partners
Investing.com
Investing.com
·
२८ मिनेट पहिले
AbbVie options flow shows 4:1 call-to-put ratio as stock rises
Yahoo Finance UK
Yahoo Finance UK
·
५ घण्टा पहिले
Will Linzess Continue to Aid Ironwood's Top-Line Growth in Q3?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees५७ हजार
Founded२०१२ अप्रिल १०
HeadquartersNorth Chicago, इलिनोइ, संयुक्त राज्य अमेरिका
Sector-
Websiteabbvie.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१५.७८ अरब
१६.६२ अरब
१५.०० अरब
१६.९९ अरब
Cost of goods sold
४.४६ अरब
४.५५ अरब
४.२२ अरब
४.२९ अरब
Cost of revenue
४.४६ अरब
४.५५ अरब
४.२२ अरब
४.२९ अरब
Research and development expenses
२.२९ अरब
२.५८ अरब
२.४७ अरब
२.३४ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.४३ अरब
३.८२ अरब
३.४९ अरब
३.५५ अरब
Operating expense
५.७२ अरब
६.४० अरब
५.९६ अरब
५.९० अरब
Total operating expenses
१०.१८ अरब
१०.९५ अरब
१०.१८ अरब
१०.१९ अरब
Operating income
५.६० अरब
५.६७ अरब
४.८२ अरब
६.८० अरब
Other non operating income
१९.९० करोड
१२.०० करोड
-३०.०० लाख
-५.५० करोड
EBT including unusual items
७१.४० करोड
२.६७ अरब
१.०४ अरब
४.२८ अरब
EBT excluding unusual items
५.११ अरब
५.१२ अरब
४.१९ अरब
६.०७ अरब
Income tax expense
५२.६० करोड
८५.३० करोड
३४.२० करोड
६६.२० करोड
Effective tax rate
७३.६७%
३१.९७%
३२.९२%
१५.४७%
Other operating expenses
-
-
-
-
Net income
१८.६० करोड
१.८२ अरब
६९.५० करोड
३.६१ अरब
Net profit margin
१.१८%
१०.९३%
४.६३%
२१.२७%
Earnings per share
१.८६
२.७१
२.६५
३.६५
Interest and investment income
७.२० करोड
५.९० करोड
७.२० करोड
६.७० करोड
Interest expense
-७३.९० करोड
-७१.४० करोड
-७१.७० करोड
-७४.६० करोड
Net interest expenses
-६६.७० करोड
-६५.५० करोड
-६४.५० करोड
-६७.९० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
७.६६ अरब
७.६६ अरब
६.७६ अरब
८.६८ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू